Breaking News
December 11, 2017 - MIT researchers discover new way to make bacteria vulnerable to existing antibiotics
December 11, 2017 - Office Workers Don’t Like Being Chained to Their Desks: MedlinePlus Health News
December 11, 2017 - Study reveals how a very low calorie diet can reverse type 2 diabetes
December 11, 2017 - University of Adelaide receives $23.2 million for preterm birth research
December 11, 2017 - Tough Flu Season Ahead: Vaccine May Only Be 10% Effective
December 11, 2017 - Getting Self-Driving Cars on the Road Soon Might Save Lives: MedlinePlus Health News
December 11, 2017 - Enterovirus vaccine prevents virus-induced diabetes in a T1D experimental model
December 11, 2017 - Solar retinopathy or sun damage to the eyes – a case report
December 11, 2017 - Cancer risk with birth control pills emerges again in latest study
December 10, 2017 - Deer Hunters: Put Safety First: MedlinePlus Health News
December 10, 2017 - High blood pressure is redefined as 130, not 140: US guidelines (Update)
December 10, 2017 - Unusual neuroinflammation may underlie cognitive problems in cART-treated HIV patients
December 10, 2017 - Racial differences in parents’ reports of child’s autism symptoms may contribute to delayed diagnosis
December 10, 2017 - Taurine could boost effectiveness of existing multiple sclerosis therapies
December 10, 2017 - The man with a young woman’s heart
December 10, 2017 - Patient bedside remains important component of medical education for students
December 10, 2017 - Nutrition labeling has little impact on sodium consumption
December 10, 2017 - ‘Obesity paradox’ not present among people with new cases of cardiovascular disease
December 10, 2017 - SLU scientists provide promising approach in designing new drugs for DMD
December 10, 2017 - Can PD-1 Inhibitor Help Eradicate HIV?
December 10, 2017 - Checking Prices for Medical Procedures Online? Good Luck: MedlinePlus Health News
December 10, 2017 - Researchers find bacteria tied to esophageal cancer
December 10, 2017 - Boy’s Double Hand Transplant Changed His Brain
December 10, 2017 - Memo to Doctors: Spit Out the Bad News: MedlinePlus Health News
December 10, 2017 - Two years of extended anastrozole therapy proved as effective as five years in clinical trial
December 10, 2017 - Using digital devices before bed may contribute to sleep and nutrition problems in children
December 10, 2017 - Are You Sure That’s What the Doctor Said About Your Leukemia?: MedlinePlus Health News
December 10, 2017 - Low vitamin D levels at birth linked to higher autism risk
December 10, 2017 - Alcohol use in movies influences onset of drinking among 10- to 15-year-olds
December 10, 2017 - For children with ADHD, a brief, school-based program can help dramatically with homework problems, study finds
December 10, 2017 - Surgical Residents Prime Candidates for Stress, Depression, Alcohol Abuse: MedlinePlus Health News
December 10, 2017 - Young athletes commonly develop bone marrow edema in the joints of the lower spine
December 10, 2017 - Coordinated approach in emergency care of heart attacks saves lives
December 10, 2017 - Patients OK With Fewer Opioids After Gallbladder Surgery
December 10, 2017 - Obamacare May Have Helped More Americans Quit Smoking: MedlinePlus Health News
December 10, 2017 - Long-term opioid use does not increase risk of Alzheimer ‘s disease
December 10, 2017 - Brief test can help determine whether drugs, talk therapy work better for treating anxiety
December 10, 2017 - Bioelectronic ‘nose’ can easily sniff foul smells in rotting food
December 10, 2017 - Spontaneous humor can be helpful for cancer patients to deal with distress
December 10, 2017 - Study finds mechanism of resistance to checkpoint inhibitors and way to reverse it
December 10, 2017 - ‘Lesser of two evils’ argument used to defend antipsychotic overuse for dementia
December 10, 2017 - Physical activity in middle age linked to lower incidence of joint symptoms
December 10, 2017 - Optogenetics research sheds new light on social-spatial learning
December 9, 2017 - Guidelines for MRI breast cancer screening not followed in community settings
December 9, 2017 - New first line combination therapy shows promising results in patients with advanced NSCLC
December 9, 2017 - Catheter-Directed Lysis Adds Risk, Not Benefit, for Proximal DVT
December 9, 2017 - Alzheimer’s Cases to Double by 2060: Report: MedlinePlus Health News
December 9, 2017 - New care model closes significant gap in addiction treatment
December 9, 2017 - PARP inhibitor can be new treatment option for patients with metastatic breast cancer, BRCA mutations
December 9, 2017 - Study shows how electrical stimulation in the brain instructs appropriate response
December 9, 2017 - Researchers develop molecular beacon to find hypoxic spots in real time
December 9, 2017 - Many Hospice Workers Lack Their Own End-of-Life Directives: MedlinePlus Health News
December 9, 2017 - New compound stops progressive kidney disease in its tracks
December 9, 2017 - Study: Changes in the brain after childhood limb loss can be reversed
December 9, 2017 - Semaglutide (Ozempic) Approved for Type 2 Diabetes
December 9, 2017 - Study Untangles Disparity in Colon Cancer Survival Rates: MedlinePlus Health News
December 9, 2017 - Lymph node surgery may raise risk of arm morbidity in younger women
December 9, 2017 - Study reveals connection between restless sleep and Parkinson’s disease
December 9, 2017 - Modern non-invasive diagnostics can get clear picture of the heart’s condition
December 9, 2017 - New method helps measure effect of one brain region on another in depression
December 9, 2017 - Mount Sinai study uses adaptive optics to examine retinal eye damage from solar eclipse
December 9, 2017 - Scientists introduce polyproline as effective cryoprotectant for monolayers of cells
December 9, 2017 - Simple molecular test may help predict presence of high-grade pancreatic cancers
December 9, 2017 - High levels of burnout, stress for U.S. surgical residents
December 9, 2017 - Parental lifespan genes could pave way for new therapeutic targets to prolong life
December 9, 2017 - About Half of Americans Get Health Care in ER: MedlinePlus Health News
December 9, 2017 - People with epilepsy may gain from common sleep apnea treatment
December 9, 2017 - Anti-impotence drug found to be ineffective at improving outcomes for IUGR pregnancies
December 9, 2017 - High risk of burnout, depression, and low quality of life found among health care workers
December 9, 2017 - Higher educational attainment associated with lower risk of Alzheimer’s disease
December 9, 2017 - Researchers seek to understand role of novel protein in tumor metastasis
December 9, 2017 - Research brings scientists one step closer to understanding development of ALS
December 9, 2017 - Women and Caregiving: Facts and Figures
December 9, 2017 - Mindfulness meditation found to relieve the stress of waiting for bad news
December 9, 2017 - Common fungus has significant impact on mosquitoes’ ability to transmit dengue virus
December 9, 2017 - Short online program improves ability of teen girls to communicate about safe sex
December 9, 2017 - Researcher discovers enzyme pathway involved in ALS pathogenesis
December 9, 2017 - Fusobacterium may play role in colon cancer growth, study finds
December 9, 2017 - Are Women Naturally Fitter Than Men?
December 9, 2017 - Celecoxib Strikes Out on Cancer Progression
Chemotherapy-generated debris from dead and dying cancer cells can stimulate tumor growth

Chemotherapy-generated debris from dead and dying cancer cells can stimulate tumor growth

image_pdfDownload PDFimage_print

Cancer therapies including radiation and chemotherapy seek to treat the disease by killing tumor cells. Now a team including researchers at Beth Israel Deaconess Medical Center (BIDMC) have shown that the dead and dying cancer cells generated by chemotherapy and targeted cancer therapy paradoxically trigger inflammation that promotes aggressive tumor growth. In a study published today in the Journal of Experimental Medicine, the team has illuminated the mechanism by which tumor cell death can drive primary tumor growth and metastasis. Moreover, the scientists also demonstrated that this unintended consequence of cancer treatment can be halted by resolvins, a family of molecules naturally produced by the human body. The findings represent a novel treatment approach to preventing tumor growth and recurrence.

“In this study we demonstrate that chemotherapy-generated debris from dead and dying tumor cells can stimulate tumor growth, which has pivotal implications for the treatment of cancer patients,” said senior author Dipak Panigrahy, MD, assistant professor of pathology in the Department of Pathology. “Conventional cancer therapy designed to kill tumor cells is inherently a double-edged sword.”

The findings are consistent with clinical observations on radiation-generated debris dating back to the 1950s, but until now, few studies investigated the molecular mechanisms underlying the phenomenon. In these studies, Panigrahy, a scientist at the Cancer Center at BIDMC, and colleagues – including lead author Megan Sulciner of BIDMC, Charles N. Serhan, Ph.D., of Brigham and Women’s Hospital (BWH), Mark W. Kieran, MD, PhD of Dana-Farber Cancer Institute, and Sui Huang, MD, PhD, of Institute of Systems Biology – injected debris from tumor cells killed by chemotherapy into animal models. Thirteen months later, the tumor cell debris alone had produced no visible tumors. However, when the researchers co-injected tumor cell debris together with as few as 100 living cancer cells that would not have resulted in cancer by themselves, the combination promoted rapid tumor growth.

The researchers’ further analysis revealed that chemotherapy-killed cancer cells promote growth when a lipid molecule exposed on the surface of dead and dying cells triggers the release of cytokines – proteins that regulate the body’s immune and inflammatory response. The resulting “cytokine storm” in the tumor’s microenvironment in turn sets the stage to promote new tumor growth.

“This pro-tumor activity could fuel a positive feedback loop that is difficult to overcome with more aggressive cytotoxic therapy like chemotherapy and radiation,” said Panigrahy. “This may explain the inherent therapeutic limit to cancer treatments available today.”

In another set of experiments, Panigrahy and colleagues attempted to block debris-stimulated tumor growth by introducing a class of anti-inflammatories produced by the human body called resolvins. Discovered by Serhan and colleagues at BWH in 2002, resolvins actively turn off inflammation and stimulate a class of immune cells to digest the tumor debris left in the wake of the cytokine storm. In this study, resolvins suppressed lung and melanoma metastasis in mouse models, the scientists found, and blocked cancer growth in various tumor models including lung, pancreatic, lymphoma, breast, prostate, and melanoma. When the researchers administered chemotherapy and resolvins to a debris-stimulated pancreatic cancer model in mice, the combination resulted in tumor regression.

The findings open the door to a new approach to prevent cancer recurrence as well as treatment by adding resolvins to existing chemotherapy of targeted therapy regimens. Already in clinical development as a potential treatment for other inflammatory disease including eczema, periodontal disease and various neurodegenerative disease, resolvins have proven to be non-toxic and come with minimal side-effects.

Source:

http://www.bidmc.org/News/PRLandingPage/2017/November/Dipak-Panigraphy.aspx

Tagged with:

About author

Related Articles